PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)

计划入组 198 人 · 首次发布于 2019 年 1 月 18 日

Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer

计划入组 235 人 · 首次发布于 2017 年 6 月 5 日

Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer

计划入组 672 人 · 首次发布于 2014 年 10 月 29 日

NR2B negative allosteric modulators (BioCrea)

HER2+ Breast Cancer(Diakonos)

CLX-001

Arvinas

United States

JAPAN BREAST CANCER RESEARCH GROUP

Japan

ANZ BREAST CANCER TRIALS GROUP LIMITED

Australia

Alpelisib Plus Fulvestrant Shows Promise in Advanced Breast Cancer With PIK3CA Mutation

NICE Approves Capivasertib-Fulvestrant Combination for Advanced Breast Cancer Treatment

AMALEE Trial Shows 400mg Ribociclib Dose Fails to Match 600mg Efficacy in Advanced Breast Cancer